Edwards Lifesciences to Trade on NYSE
- Share via
Edwards Lifesciences Corp., the Irvine cardiovascular division of Baxter International Inc. that is being spun off, is scheduled to begin trading April 3 on the New York Stock Exchange under the ticker symbol EW. Edwards also named two new directors--Mike R. Bowlin, chairman and chief executive of Atlantic Richfield Co., and Victoria R. Fash, president and chief executive of IMS Health, a provider of information solutions to the pharmaceutical and health care industries.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
